Endovascular Engineering (E2) has secured an oversubscribed $42m in a Series B funding round to further its clot removal technology platform, Hēlo PE thrombectomy system, targeting venous ...

("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology ... solutions for addressing Pulmonary Embolism (PE).